Treatment for Aortic Valve Disease
Phase-Based Progress Estimates
Effectiveness
Safety
Aortic Valve Disease+3 More
Eligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is studying the Trifecta valve, which is used to treat heart valve disease. They are following patients for 5 years to see how well it works and if it is safe.
Eligible Conditions
- Aortic Valve Disease
- Aortic valve disorder
- Aortic Valve Disorder
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 5 years post implant
5 years post implant
Freedom from all-cause mortality
Freedom from structural valve deterioration
Freedom from surgical valve replacement or transcatheter valve implantation due to structural valve deterioration
Freedom from surgical valve replacement or transcatheter valve-in-valve implantation
Freedom from valve related mortality
Year 5
Valve hemodynamic performance
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
363 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years post implant
Who is running the clinical trial?
Abbott Medical DevicesLead Sponsor
599 Previous Clinical Trials
362,888 Total Patients Enrolled
6 Trials studying Aortic Valve Disease
2,822 Patients Enrolled for Aortic Valve Disease
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:The subject must be willing and able to provide written consent to participate in this study.
The subject is a candidate for surgery to replace their aortic valve, and they are expected to have a St
The person is of legal age in the country where they are studying.
The subject must be willing and able to comply with all follow-up requirements.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments